Matchless Case-Based Learning in Mitral and Tricuspid Disease Is in Store This December

For several years running, Cleveland Clinic has offered a valve-focused CME event in the heart of New York City in the lead-up to the December holidays, with the focus alternating from year to year between the aortic and mitral valves. This year the spotlight returns to the mitral valve, but now with a broadened scope to include detailed discussion of tricuspid valve disease as well.

The day-and-a-half course, “Case-Based Management of Tricuspid and Mitral Valve Disease 2024,” will be held Friday and Saturday, Dec. 6-7, at the JW Marriott Essex House in midtown Manhattan, just south of Central Park.

“We’ve expanded the agenda to the tricuspid valve to address the evolving management of tricuspid valve disease with the emergence of new interventional therapies,” says course co-director Brian Griffin, MD, Section Head of Cardiovascular Imaging at Cleveland Clinic.

“The landscape for management of mitral and tricuspid valve disease is changing rapidly,” adds course co-director Marc Gillinov, MD, Chair of Thoracic and Cardiovascular Surgery. “Using a case-based approach, a multidisciplinary faculty will highlight the complex decision-making involved in choosing the best therapy for each patient.”

More case-focused than ever

In fact, the popular course’s case-based nature is stronger than ever this year, with case-based discussions comprising a large majority of each of its nine sessions. The sessions are focused on the following topics:

• Evolution of the mitral valve disease landscape
• Management of tricuspid valve disease
• Ventricular arrhythmias and mitral regurgitation
• Atrial arrhythmias and mitral regurgitation
• State of the art in transcatheter edge-to-edge repair
• Ischemic mitral regurgitation
• Torrential tricuspid regurgitation
• When and how to address the mitral valve in hypertrophic obstructive cardiomyopathy

Additionally, the final session of the course consists exclusively of five complex case-based scenarios.

Imaging, interventional, surgery, EP and more

What makes the course’s case-based discussions distinctive is that most include management perspectives from multiple subspecialties, including cardiovascular imaging, interventional cardiology, cardiac surgery, electrophysiology and others. These perspectives come from a faculty of 12 experts in these areas from Cleveland Clinic and leading institutions in the New York metro area.

“We have designed this meeting to combine case-based, cutting-edge discussions in all aspects of the diagnosis and management of mitral and tricuspid valve disease,” notes course co-director Milind Desai, MD, MBA, Vice Chair of Education for Cleveland Clinic’s Heart, Vascular & Thoracic Institute and a leading cardiologist in its Valve Center. “It will include lively discussions on multimodality imaging and on state-of-the-art surgical and structural interventions, including implications of the latest trial data.”

The agenda is notable for its frequent integration of imaging and electrophysiology considerations into virtually all the subtopics covered, ensuring comprehensive exploration of all case scenarios discussed. Other agenda highlights include a review of lessons from recent trials of various transcatheter tricuspid interventions, a debate on surgery versus interventional management of ischemic mitral regurgitation, and discussions around surgical management of combined mitral and tricuspid valve disease.

“This course will be a great resource for those interested in the latest on complex mitral and tricuspid valve surgery and the many nuanced clinical considerations leading up to it,” concludes course co-director Lars Svensson, MD, PhD, Chief of the Heart, Vascular & Thoracic Institute. “We look forward to engaging discussions with colleagues from near and far.”

Register or learn more at ccfcme.org/mitralvalve. Early-bird pricing ends Oct. 15.

This activity has been approved for AMA PRA Category 1 Credit™.